Mandate

Vinge advised Orexo on its divestment of Kibion

May 05, 2015

Orexo AB (publ) (Nasdaq Stockholm) has divested its subsidiary Kibion to a group of investors. Vinge advised Orexo.

The Vinge team included Erik Sjöman (partner, capital markets and M&A) and associates Christian Lindhé, Kristoffer Franzkeit and Cecilia Cronqvist.

Related

Vinge has advised Studentbostäder i Norden AB in connection with its rights issue

Vinge has advised Studentbostäder i Norden AB (publ), a real estate company whose shares are listed on Nasdaq First North Premier Growth Market, in connection with an oversubscribed rights issue amounting to approximately SEK 145 million before deduction of transaction costs.
April 25, 2025

Vinge advises Axcel and Accru Partners in connection with the acquisitions of Carlstedt & Lindh AB and Brahe Revisionsbyrå AB

Vinge has advised Axcel VII and Accru Partners in connection with the acquisitions of Carlstedt & Lindh AB and Brahe Revisionsbyrå AB
April 24, 2025

Vinge advises Biotage in connection with RWK Bidco’s public tender

On 22 April 2025, RWK Bidco AB, a newly formed company indirectly wholly owned by KKR Funds, announced a public tender offer to the shareholders in Biotage AB to tender all ordinary shares in Biotage to RWK Bidco at a price of SEK 145 in cash per ordinary share.
April 22, 2025